The role of antibiotics in acute exacerbations of chronic obstructive pulmonary disease
- Sanjay Sethi MD
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Our understanding of the pathogenesis and consequences of acute exacerbations of chronic obstructive pulmonary disease (COPD) has increased considerably in the past decade. Several new lines of evidence support bacterial causation of about half the exacerbations. Contrary to previous data, recent studies with improved methodology have demonstrated that exacerbations do contribute to the loss of lung function in COPD. Another interesting new observation is that colonization by bacterial pathogens may not be innocuous, and in fact may lead to airway inflammation and contribute to pathogenesis of COPD. Evidence that bacteria cause exacerbations, that exacerbations contribute to loss of lung function, and that chronic colonization by bacteria may be harmful, has emphasized the potential importance of appropriate antibiotics in the treatment of exacerbations. An unfortunate paucity of data does not allow evidence-based recommendations to be made for optimal choice of antibiotics for exacerbations of COPD. Emerging data that antibiotics differ in unconventional measures of efficacy such as time to next exacerbation, improvement in health-related quality of life, and bacteriologic eradication will help us make concrete recommendations in the future.
- Hirschmann JV: Do bacteria cause exacerbations of COPD? Chest 2000, 118:193–203. Most recent published debate on the role of bacteria in COPD. CrossRef
- Murphy TF, Sethi S, Niederman MS: The role of bacteria in exacerbations of COPD. A constructive view. Chest 2000, 118:204–209. Another recently published debate on the role of bacteria in COPD. CrossRef
- Sethi S: Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000, 117:380S-385S. CrossRef
- Tager I, Speizer FE: Role of infection in chronic bronchitis. N Engl J Med 1975, 292:563–571. CrossRef
- Murphy TF, Sethi S: Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992, 146:1067–1083.
- Isada CM: Pro: Antibiotics for chronic bronchitis with exacerbations. Semin Respir Infect 1993, 8:243–253.
- Nicotra MB Kronenberg S: Con: antibiotic use in exacerbations of chronic bronchitis. Semin Respir Infect 1993, 8:254–258.
- Smith CB, Golden C, Klauber MR, et al.: Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976, 134:552–561.
- Gump DW, Phillips CA, Forsyth BR, et al.: Role of infection in chronic bronchitis. Am Rev Respir Dis 1976, 113:465–473.
- Saint S, Bent S, Vittinghoff E, et al.: Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 1995, 273:957–966. CrossRef
- Sethi S, Murphy TF: Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001, 14:336–363. A comprehensive review of the major bacterial pathogens implicated in COPD. CrossRef
- Fagon J-Y, Chastre J, Trouillet J-L, et al.: Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis 1990, 142:1004–1008.
- Monso E, Ruiz J, Rosell A, et al.: Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995, 152:1316–1320.
- Pela R, Marchesani F, Agostinelli C, et al.: Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch Chest Dis 1998, 53:262–267.
- Soler N, Torres A, Ewig S, et al.: Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998, 157:1498–1505.
- Sethi S, Muscarella K, Evans N, et al.: Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000, 118:1557–1565. CrossRef
- Gompertz S, O’Brien C, Bayley DL, et al.: Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001, 17:1112–1119. CrossRef
- Yi K, Sethi S, Murphy T: Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. J Infect Dis 1997, 176:1247–1252.
- Bakri F, Brauer AL, Sethi S, et al.: Systemic and mucosal antibody response to Moraxella catarrhalis following exacerbations of chronic obstructive pulmonary disease. J Infect Dis 2002, 185:632–640. CrossRef
- Sethi S, Evans N, Grant BJB, et al.: Acquisition of a new bacterial strain and occurrence of exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465–471. Recently published study demonstrating the new acquisition of bacterial strains increases the risk of exacerbation. CrossRef
- Howard P: A long-term follow-up of respiratory symptoms and ventilatory function in a group of working men. Br J Industr Med 1970, 27:326–333.
- Bates DV: The fate of the chronic bronchitic: a report of the ten-year follow-up in the Canadian Department of Veteran’s Affairs coordinated study of chronic bronchitis. Am Rev Respir Dis 1973, 108:1043–1065.
- Fletcher F, Peto R: Natural history of chronic airflow obstruction. Br Med J 1977, 13:1645–1648.
- Howard P: Evolution of the ventilatory capacity in chronic bronchitis. Br Med J 1967, 3:392–395. CrossRef
- Kanner R, Renzetti AD Jr, Klauber MR, et al.: Variables associated with changes in spirometry in patients with obstructive lung diseases. Am J Med 1979, 67:44–50. CrossRef
- Kanner R, Anthonisen NR, Connett JE, et al.: Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001, 164:358–364. Large study showing that exacerbation contributes to loss of lung function in early COPD.
- Seemungal TAR, Donaldson GC, Bhowmik A, et al.: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1608–1613.
- Laurenzi GA, Potter RT, Kass EH: Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961, 265:1273–1278. CrossRef
- Khair OA, Davies RJ, Devalia JL: Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996, 9:1913–1922. CrossRef
- Soler N, Ewig S, Torres A, et al.: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999, 14:1015–1022. CrossRef
- Wilson R, Schentag JJ, Ball P, Mandell L: A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther 2002, 24:639–652. Antibiotic comparison trial with unconventional endpoints. CrossRef
- Jones PW Spencer S, on behalf of the GLOBE Study Group: Patients with recurrent AECB have poorer health and recover more slowly and less completely after an acute episode: the GLOBE study. Paper present at 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto. September 17–20, 2000.
- The role of antibiotics in acute exacerbations of chronic obstructive pulmonary disease
Current Infectious Disease Reports
Volume 5, Issue 1 , pp 9-15
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links
- Sanjay Sethi MD (1)
- Author Affiliations
- 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Buffalo State University of New York and Department of Veterans Affairs Western New York Health Care System, 3495 Bailey Avenue, 14215, Buffalo, NY, USA